Skip to Main Content

Paper Details

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.
Cell Death Dis
24
2021
Glioblastoma, Glioblastoma cell line models, HOTAIRM1, HOXA, HOXA Transcript Antisense RNA, HOXA Transcript Antisense RNA, Myeloid-Specific 1, IDH, IDH mutation, Long non-coding RNAs, MGMT, MGMT promoter, O6-methylguanine, O6-methylguanine DNA methyltransferase, TGM2, glioblastoma, glioblastoma cells, isocitrate, isocitrate dehydrogenase (IDH) gene 1 or 2, lncRNA, lncRNAs, long non-coding RNA HOTAIRM1, malignant primary brain tumor, oxygen, patients, transglutaminase 2, tumor
Author NameAffiliation
Daniel PicardGerman Cancer Research Center (DKFZ)
Daniel Picard
Daniel Picardand Clinical Immunology, University Hospital Dusseldorf
Daniel PicardHeinrich Heine University
Jasmin BartlGerman Cancer Research Center (DKFZ)
Jasmin Bartl
Jasmin Bartland Clinical Immunology, University Hospital Dusseldorf
Jasmin BartlHeinrich Heine University
Nan QinGerman Cancer Research Center (DKFZ)
Nan Qin
Nan Qinand Clinical Immunology, University Hospital Dusseldorf
Nan QinHeinrich Heine University
Lena Bl??melGerman Cancer Research Center (DKFZ)
Lena Bl??mel
Lena Bl??meland Clinical Immunology, University Hospital Dusseldorf
Lena Bl??melHeinrich Heine University
Marietta WolterHeinrich Heine University
David PauckGerman Cancer Research Center (DKFZ)
David Pauck
David Pauckand Clinical Immunology, University Hospital Dusseldorf
David PauckHeinrich Heine University
Viktoria MarquardtGerman Cancer Research Center (DKFZ)
Viktoria Marquardt
Viktoria Marquardtand Clinical Immunology, University Hospital Dusseldorf
Viktoria MarquardtHeinrich Heine University
Anja StefanskiInstitute for Molecular Medicine I, Heinrich Heine University
Anja StefanskiBiological-Medical Research Center (BMFZ), Heinrich Heine University
Frauke-Dorothee MeyerGerman Cancer Research Center (DKFZ)
Frauke-Dorothee Meyer
Frauke-Dorothee Meyerand Clinical Immunology, University Hospital Dusseldorf
Frauke-Dorothee MeyerHeinrich Heine University
Ute Fischerand Clinical Immunology, University Hospital Dusseldorf
Gabriel LeprivierHeinrich Heine University
Kai St??hlerInstitute for Molecular Medicine I, Heinrich Heine University
Kai St??hlerBiological-Medical Research Center (BMFZ), Heinrich Heine University
Simone FuldaInstitute for Experimental Cancer Research in Pediatrics, Goethe University Frankfurt
Simone FuldaPartner Site Frankfurt and German Cancer Research Center (DKFZ)
Arndt BorkhardtGerman Cancer Research Center (DKFZ)
Arndt Borkhardtand Clinical Immunology, University Hospital Dusseldorf
Arndt Borkhardt
Arndt BorkhardtGerman Cancer Research Center (DKFZ)
Arndt Borkhardt
Arndt Borkhardtand Clinical Immunology, University Hospital Dusseldorf
Michael WellerUniversity Hospital and University of Zurich
Guido ReifenbergerGerman Cancer Research Center (DKFZ)
Guido Reifenberger
Guido ReifenbergerHeinrich Heine University
Marc RemkeGerman Cancer Research Center (DKFZ)
Marc Remke
Marc Remkeand Clinical Immunology, University Hospital Dusseldorf
  • 1 - 50

Datasets

Release 1.2